| The genetic architecture of type 2 diabetes C Fuchsberger, J Flannick, TM Teslovich, A Mahajan, V Agarwala, ... Nature 536 (7614), 41-47, 2016 | 1249 | 2016 |
| An expanded genome-wide association study of type 2 diabetes in Europeans RA Scott, LJ Scott, R Mägi, L Marullo, KJ Gaulton, M Kaakinen, ... Diabetes 66 (11), 2888-2902, 2017 | 734 | 2017 |
| Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci KJ Gaulton, T Ferreira, Y Lee, A Raimondo, R Mägi, ME Reschen, ... Nature genetics 47 (12), 1415-1425, 2015 | 417 | 2015 |
| Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial JM Crook, A Gomez-Iturriaga, K Wallace, C Ma, S Fung, S Alibhai, ... Journal of Clinical Oncology 29 (4), 362-368, 2011 | 215 | 2011 |
| Recommended joint and meta‐analysis strategies for case‐control association testing of single low‐count variants C Ma, T Blackwell, M Boehnke, LJ Scott, GoT2D Investigators Genetic epidemiology 37 (6), 539-550, 2013 | 178 | 2013 |
| Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes AR Majithia, J Flannick, P Shahinian, M Guo, MA Bray, P Fontanillas, ... Proceedings of the National Academy of Sciences 111 (36), 13127-13132, 2014 | 177 | 2014 |
| Interconversion of three measures of performance status: an empirical analysis C Ma, S Bandukwala, D Burman, J Bryson, D Seccareccia, S Banerjee, ... European Journal of Cancer 46 (18), 3175-3183, 2010 | 176 | 2010 |
| Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of … KG Weinacht, LM Charbonnier, F Alroqi, A Plant, Q Qiao, H Wu, C Ma, ... Journal of Allergy and Clinical Immunology 139 (5), 1629-1640. e2, 2017 | 167 | 2017 |
| An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients NG Chau, C Ma, K Danga, H Al-Sayegh, V Nardi, R Barrette, CS Lathan, ... JNCI Cancer Spectrum 4 (2), pkz094, 2020 | 149 | 2020 |
| Radiation therapy in the management of the primary penile tumor: an update J Crook, C Ma, L Grimard World journal of urology 27, 189-196, 2009 | 136 | 2009 |
| Factors associated with work stress and professional satisfaction in oncology staff E Dougherty, B Pierce, C Ma, T Panzarella, G Rodin, C Zimmermann American Journal of Hospice and Palliative Medicine® 26 (2), 105-111, 2009 | 124 | 2009 |
| 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients J Crook, J Borg, A Evans, A Toi, EP Saibishkumar, S Fung, C Ma International Journal of Radiation Oncology* Biology* Physics 80 (5), 1323-1329, 2011 | 122 | 2011 |
| Non–risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital’s experience JF Sturgeon, MJ Moore, DM Kakiashvili, I Duran, LC Anson-Cartwright, ... European urology 59 (4), 556-562, 2011 | 120 | 2011 |
| Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer H Lara-Guerra, TK Waddell, MA Salvarrey, AM Joshua, CT Chung, N Paul, ... Journal of Clinical Oncology 27 (36), 6229, 2009 | 116 | 2009 |
| The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials P Wheatley-Price, F Blackhall, SM Lee, C Ma, L Ashcroft, M Jitlal, W Qian, ... Annals of oncology 21 (10), 2023-2028, 2010 | 113 | 2010 |
| Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma P Wheatley-Price, B Yang, D Patsios, D Patel, C Ma, W Xu, N Leighl, ... Journal of clinical oncology 28 (20), 3316-3322, 2010 | 106 | 2010 |
| DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. An expanded genome-wide association study of type 2 diabetes in Europeans RA Scott, LJ Scott, R Mägi, L Marullo, KJ Gaulton, M Kaakinen, ... Diabetes 66 (11), 2888-2902, 2017 | 101 | 2017 |
| Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis PA Bradbury, R Zhai, J Hopkins, MH Kulke, RS Heist, S Singh, W Zhou, ... Carcinogenesis 30 (5), 793-798, 2009 | 100 | 2009 |
| Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes PA Bradbury, MH Kulke, RS Heist, W Zhou, C Ma, W Xu, AL Marshall, ... Pharmacogenetics and genomics 19 (8), 613-625, 2009 | 97 | 2009 |
| Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival AE Marinoff, C Ma, D Guo, M Snuderl, KD Wright, PE Manley, ... Journal of neuro-oncology 135, 201-211, 2017 | 94 | 2017 |
